Molecules in focus: indoleamine 2,3-dioxygenase - PubMed (original) (raw)
Review
Molecules in focus: indoleamine 2,3-dioxygenase
Nicholas J C King et al. Int J Biochem Cell Biol. 2007.
Abstract
Indoleamine 2,3-dioxygenase (IDO) is a heme enzyme that initiates the oxidative degradation of the least abundant, essential amino acid, l-tryptophan, along the kynurenine pathway. The local cellular depletion of l-tryptophan that results may enable the host to inhibit the growth of various infectious pathogens in vivo. However, over the past decade, it has become increasingly apparent that IDO also represents an important immune control enzyme. Thus, cells expressing IDO, seemingly paradoxically, are capable of suppressing local T cell responses to promote immune tolerance under various physiological and pathophysiological conditions of medical importance, including infectious diseases, foetal rejection, organ transplantation, neuropathology, inflammatory and auto-immune disorders and cancer. In this review, we briefly outline the biochemical properties of IDO, its known and hypothetical functions and the medical implications for inhibition or induction of IDO and/or its downstream catabolites in health and disease.
Similar articles
- Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M, Germenis AE, Karanikas V. Zamanakou M, et al. Immunol Lett. 2007 Aug 15;111(2):69-75. doi: 10.1016/j.imlet.2007.06.001. Epub 2007 Jul 2. Immunol Lett. 2007. PMID: 17644189 Review. - Indoleamine 2,3 dioxygenase and regulation of T cell immunity.
Mellor A. Mellor A. Biochem Biophys Res Commun. 2005 Dec 9;338(1):20-4. doi: 10.1016/j.bbrc.2005.08.232. Epub 2005 Sep 8. Biochem Biophys Res Commun. 2005. PMID: 16157293 Review. - Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
López AS, Alegre E, LeMaoult J, Carosella E, González A. López AS, et al. Mol Immunol. 2006 Jul;43(14):2151-60. doi: 10.1016/j.molimm.2006.01.007. Epub 2006 Feb 21. Mol Immunol. 2006. PMID: 16490253 - The immunoregulatory role of IDO-producing human dendritic cells revisited.
Terness P, Chuang JJ, Opelz G. Terness P, et al. Trends Immunol. 2006 Feb;27(2):68-73. doi: 10.1016/j.it.2005.12.006. Epub 2006 Jan 10. Trends Immunol. 2006. PMID: 16406698 - Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T, Danese S, De Cristofaro R, Rutella S. Di Pucchio T, et al. Expert Opin Ther Pat. 2010 Feb;20(2):229-50. doi: 10.1517/13543770903512974. Expert Opin Ther Pat. 2010. PMID: 20100004 Review.
Cited by
- Distinct strategies are required to suppress antigen-specific responses to genetically modified keratinocytes and fibroblasts.
Ghazizadeh S, Huang LT, Zhang W. Ghazizadeh S, et al. Mol Ther. 2012 Jan;20(1):196-203. doi: 10.1038/mt.2011.205. Epub 2011 Oct 11. Mol Ther. 2012. PMID: 21988876 Free PMC article. - Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function.
Becerra A, Warke RV, Xhaja K, Evans B, Evans J, Martin K, de Bosch N, Rothman AL, Bosch I. Becerra A, et al. J Gen Virol. 2009 Apr;90(Pt 4):810-817. doi: 10.1099/vir.0.004416-0. Epub 2009 Mar 4. J Gen Virol. 2009. PMID: 19264674 Free PMC article. - Ingestion of Lactobacillus rhamnosus modulates chronic stress-induced feather pecking in chickens.
Mindus C, van Staaveren N, Bharwani A, Fuchs D, Gostner JM, Kjaer JB, Kunze W, Mian MF, Shoveller AK, Forsythe P, Harlander-Matauschek A. Mindus C, et al. Sci Rep. 2021 Aug 24;11(1):17119. doi: 10.1038/s41598-021-96615-x. Sci Rep. 2021. PMID: 34429482 Free PMC article. - Role of indoleamine 2,3-dioxygenase in ischemia-reperfusion injury of renal tubular epithelial cells.
Eleftheriadis T, Pissas G, Golfinopoulos S, Liakopoulos V, Stefanidis I. Eleftheriadis T, et al. Mol Med Rep. 2021 Jun;23(6):472. doi: 10.3892/mmr.2021.12111. Epub 2021 Apr 26. Mol Med Rep. 2021. PMID: 33899121 Free PMC article. - Myeloid-derived suppressor cells are associated with impaired Th1 and Th17 responses and severe pulmonary paracoccidioidomycosis which is reversed by anti-Gr1 therapy.
Preite NW, Kaminski VL, Borges BM, Calich VLG, Loures FV. Preite NW, et al. Front Immunol. 2023 Jan 26;14:1039244. doi: 10.3389/fimmu.2023.1039244. eCollection 2023. Front Immunol. 2023. PMID: 36776848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous